Skip to main content
. 2020 Sep 11;4:129. Originally published 2019 Sep 4. [Version 2] doi: 10.12688/wellcomeopenres.15408.2

Figure 2. Summary of the payment mechanism for the drug costs relating to interferon-based treatment from the national health insurance programme.

Figure 2.

Information adapted from 16, 33. NHI: National health insurance programme.